Skip to content
10-Q

Quarterly Report

BioAmber Inc.

0001564590-17-022850

← back to feed
Filed
Nov 8, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Nov 8, 2017 52.11M sh
Long Term Debt Q3 2017 · Sep 30, 2017 $25.41M
Long Term Debt Q3 2017 · Dec 31, 2016 $29.03M
Short Term Debt Q3 2017 · Sep 30, 2017 $11.79M
Short Term Debt Q3 2017 · Dec 31, 2016 $23.3M
Cash And Equivalents Q3 2017 · Sep 30, 2017 $10.23M
Cash And Equivalents Q3 2017 · Dec 31, 2016 $16.16M
Cash And Equivalents Q3 2017 · Sep 30, 2016 $15.94M
Cash And Equivalents Q3 2017 · Dec 31, 2015 $6.97M
Stockholders Equity Q3 2017 · Sep 30, 2017 $106.79M
Stockholders Equity Q3 2017 · Dec 31, 2016 $48.49M
Current Liabilities Q3 2017 · Sep 30, 2017 $18.82M
Current Liabilities Q3 2017 · Dec 31, 2016 $45.3M
Total Liabilities Q3 2017 · Sep 30, 2017 $48.73M
Total Liabilities Q3 2017 · Dec 31, 2016 $75.32M
Current Assets Q3 2017 · Sep 30, 2017 $20.33M
Current Assets Q3 2017 · Dec 31, 2016 $31.42M
Total Assets Q3 2017 · Sep 30, 2017 $155.52M
Total Assets Q3 2017 · Dec 31, 2016 $161.33M
Sga Expense Q3 2017 · Sep 30, 2017 $2.32M
Sga Expense Q3 2017 · Sep 30, 2017 $10.13M
Sga Expense Q3 2017 · Sep 30, 2016 $1.77M
Sga Expense Q3 2017 · Sep 30, 2016 $7.38M
Rd Expense Q3 2017 · Sep 30, 2017 $1.19M
Rd Expense Q3 2017 · Sep 30, 2017 $4.29M
Rd Expense Q3 2017 · Sep 30, 2016 $1.77M
Rd Expense Q3 2017 · Sep 30, 2016 $5.14M
Net Income Q3 2017 · Sep 30, 2017 −$7.05M
Net Income Q3 2017 · Sep 30, 2017 −$14.08M
Net Income Q3 2017 · Sep 30, 2016 −$6.16M
Net Income Q3 2017 · Sep 30, 2016 −$12.29M
Operating Income Q3 2017 · Sep 30, 2017 −$8.08M
Operating Income Q3 2017 · Sep 30, 2017 −$26.5M
Operating Income Q3 2017 · Sep 30, 2016 −$6.57M
Operating Income Q3 2017 · Sep 30, 2016 −$22.39M